STATEMENT: BIOGEN PROVIDES UPDATE ON THE ACQUISITION OF REATA PHARMACEUTICALS
STATEMENT: BIOGEN PROVIDES UPDATE ON THE ACQUISITION OF REATA PHARMACEUTICALS
September 21, 2023
Biogen confirms that today Reata Pharmaceuticals announced in a special meeting the stockholders of the company voted to approve the company’s previously announced acquisition by Biogen. For more information, read Reata’s Form 8-K disclosure.
